Back to basics: Hematoxylin and eosin staining is the principal tool for histopathological risk assessment of oral cancer

Affiliations

• ¹ Department of Pathology, University of Helsinki, Helsinki, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Institute of Biomedicine, Pathology, University of Turku, Turku, Finland; Faculty of Dentistry, University of Misurata, Misurata, Libya. Electronic address: alhadi.almangush@helsinki.fi.
• ² Department of Otorhinolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden. Electronic address: antti.makitie@helsinki.fi.
• ³ Institute of Biomedicine, Pathology, University of Turku, Turku, Finland. Electronic address: ilmo.leivo@utu.fi.